Lantern Pharma Inc. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lantern Pharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
  • Lantern Pharma Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.18M, a 47% decline year-over-year.
  • Lantern Pharma Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$21.2M, a 26% decline year-over-year.
  • Lantern Pharma Inc. annual Operating Income (Loss) for 2023 was -$17.9M, a 23.9% decline from 2022.
  • Lantern Pharma Inc. annual Operating Income (Loss) for 2022 was -$14.4M, a 14.6% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$21.2M -$5.18M -$1.66M -47% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$19.5M -$5.41M -$218K -4.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$19.3M -$5.73M -$1.45M -33.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$17.9M -$4.88M -$1.05M -27.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 -$16.8M -$3.52M -$1.38M -64.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$15.4M -$5.19M -$795K -18.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$14.7M -$4.29M -$220K -5.41% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$14.4M -$3.83M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$2.15M +$2M +48.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$4.39M -$1.92M -77.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$4.07M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 -$4.15M -$2.45M -144% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$2.48M -$1.65M -197% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q3 2020 -$1.7M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 -$833K Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.